EPIRUS BIOPHARMACEUTICALS INC COM (EPRSQ)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

245 FIRST STREET CAMBRIDGE, MA 02142

Operates as a development stage biopharmaceutical company. Focuses on developing new medicines built from synergistic combinations of approved drugs. The company has a portfolio of seven product candidates targeting multiple immuno-inflammatory diseases and cancer.

View SEC Filings from EPRSQ instead.

View recent insider trading info

Funds Holding EPRSQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EPRSQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WYAND MICHAEL PRESIDENT AND COO

  • Officer
0 2016-05-27 0

SHEA THOMAS A. CHIEF FINANCIAL OFFICER

  • Officer
0 2016-05-27 0

TICKTIN ROBERT GENERAL COUNSEL

  • Officer
0 2016-05-27 0

AURENTZ VINCENT CHIEF BUSINESS OFFICER

  • Officer
0 2016-05-27 0

MUNSHI AMIT CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
177,083 2016-02-27 0

DUYK GEOFFREY M

  • Director
0 2015-06-05 0

BUCHI J KEVIN

  • Director
0 2015-06-05 0

ROCKLAGE SCOTT M

  • Director
  • 10% Owner
0 2015-06-05 0

CORRIGAN MARK

  • Director
0 2015-06-05 0

HUNTER WILLIAM L

  • Director
0 2015-06-05 0

MCHUGH JULIE

  • Director
0 2015-06-05 0

FU DAOTIAN

  • Director
0 2015-06-05 0

MONTREUX EQUITY PARTNERS IV LP

MONTREUX EQUITY PARTNERS V, L.P.

  • 10% Owner
1,942,876 2015-02-05 0

5AM PARTNERS III, LLC

5AM VENTURES III, L.P.

5AM CO-INVESTORS III, L.P.

SCHWAB ANDREW J.

DIEKMAN JOHN D

  • 10% Owner
2,614,910 2015-02-04 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
22,239,223 2014-07-15 0

SETH KIM CHIEF BUSINESS OFFICER

  • Officer
0 2014-07-15 0

LIVZON MABPHARM INC.

  • 10% Owner
15,660,235 2014-07-15 0

RENZ JUSTIN A EVP, CFO & TREASURER

  • Officer
250,000 2014-02-10 0

CRAWFORD SALLY

  • Director
0 2013-06-06 0

HAYDU FRANK

  • Director
0 2013-06-06 0

OSHEA WILLIAM J

  • Director
0 2013-06-06 0

KAUFFMAN MICHAEL

  • Director
0 2013-06-06 0

COLE JASON EVP,CORP DEV & GENERAL COUNSEL

  • Officer
0 2013-01-03 0

FOLEY TODD

  • Director
0 2012-05-23 0

GALLEN CHRISTOPHER C. EVP RESEARCH & DEVELOPMENT

  • Officer
1,842,986 2012-02-29 0

EVNIN LUKE

GALAKATOS NICHOLAS

HENNER DENNIS

STEINMETZ MICHAEL

GADICKE ANSBERT

SIMON NICHOLAS J III

WHEELER KURT

  • 10% Owner
11,133,961 2011-10-27 0

MPM BIOVENTURES III LLC

MPM BIOVENTURES III PARALLEL FUND, L.P.

MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES III L.P.

MPM BIOVENTURES III GP L.P.

MPM BIOVENTURES III-QP L.P.

MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC

MPM ASSET MANAGEMENT LLC

  • 10% Owner
11,133,961 2011-10-27 0

RICHARDSON HARTLEY T

  • Director
0 2011-05-24 0

WRIGHT C. EUGENE SVP & CHIEF DEV OFFICER

  • Officer
48,280 2010-03-01 0

SNUTCH TERRANCE P. SVP & CHIEF SCIENTIFIC OFFICER

  • Officer
602,603 2010-03-01 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

LAMPERT MARK N

BVF INC/IL

  • 10% Owner
  • DIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNER
No longer subject to file 2009-12-22 0

FORRESTER ROBERT EVP AND COO

  • Officer
  • Director
0 2009-12-21 0

BORISY ALEXIS CEO & PRESIDENT

  • Officer
  • Director
312,204 2009-01-26 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
10,008,871 2008-12-05 0

BAIRD LYNN G SENIOR VP - REGULATORY AFFAIRS

  • Officer
0 2008-07-15 0

RANDLE JOHN SVP COMMERCIAL DEVELOPMENT

  • Officer
0 2008-07-15 0

FORTUNE PATRICK J

  • Director
0 2008-05-29 0

POPS RICHARD F

  • Director
0 2008-05-29 0

DEPTULA BARBARA

  • Director
0 2008-05-29 0

KEITH CURTIS T SVP, RESEARCH

  • Officer
65,485 2008-01-26 0

GRAU DANIEL CHIEF OPERATING OFFICER

  • Officer
34,125 2008-01-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments